Contact this trialFirst, we need to learn more about you.
MDM2 Inhibitor
Brigimadlin + Radiation for Glioblastoma
Recruiting1 awardPhase 1
Rochester, Minnesota
This trial is for a new cancer drug that is taken before surgery to remove a brain tumor. Part one is to see how well the drug is taken up by the tumor and part two is to see what the highest dose is that patients can tolerate in combination with standard radiation therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.